Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Tables)

v3.19.1
Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Tables)
3 Months Ended
Mar. 31, 2019
Tables/Schedules  
Schedule of Notes receivable from G Farma

 

 

 

March 31, 2019

 

December 31, 2018

Real estate note

$

110,589

$

111,843

Working capital note

 

930,793

 

909,507

Impairment recorded

 

(992,114)

 

-

Note receivable discount

 

-

 

(7,591)

Accrued interest

 

-

 

3,067

 

 

49,268

 

1,016,826

Less current portion

 

(49,268)

 

(45,173)

Long term portion of notes receivable

$

-

$

971,653